and Shahla Abdollahi-Roodsaz 3 Objective. Intestinal microbiota are associated with the development of inflammatory arthritis. The aim of this study was to dissect intestinal mucosal immune responses in the preclinical phase of arthritis and determine whether the presence of Th17 cells, beyond involvement of the cytokine interleukin-17 (IL-17), is required for arthritis development, and whether the involvement of Th17 cells in arthritis depends on the composition of the host microbiota.
Methods. Mucosal T cell production of IL-17, interferon-c, tumor necrosis factor a (TNFa), IL-22, and granulocyte-macrophage colony-stimulating factor (GM-CSF) was analyzed by flow cytometry and Luminex assay before arthritis onset in mice immunized to develop collageninduced arthritis (CIA). Pathogenic features of arthritis in mice with CIA and mice with antigen-induced arthritis were compared between Th17 cell-deficient (CD4-Cre ) and Th17 cell-sufficient (CD4-Cre À Rorc flox/flox ) mice. In addition, the impact of intestinal microbiota on the Th17 cell dependence of CIA was assessed.
Results. Lamina propria CD4 T cells were activated before the onset of arthritis in mice with CIA, with marked up-regulation of several cytokines, including IL-17A, TNFa, and GM-CSF. CD4-Cre + Rorc flox/flox mice showed a specific reduction in intestinal mucosal levels of Th17 cells and partially reduced levels of IL-17-producing CD8 T cells. However, total levels of IL-17A, mostly produced by cd T cells and neutrophils, were unaffected. The severity of arthritis was significantly reduced in Th17 cell-deficient mice, suggesting that Th17 cells have additional, IL-17A-independent roles in inflammatory arthritis. Accordingly, antigen-stimulated T cells from Th17 cell-deficient mice produced less IL-17A, IL-17F, and GM-CSF. Importantly, the dependence of CIA on the involvement of Th17 cells was mitigated in the presence of an alternative microbiome.
Conclusion. These data from murine models suggest that activation of mucosal immunity precedes the development of arthritis, and also that Th17 cells have a microbiota-dependent role in arthritis. Therefore, a microbiome-guided stratification of patients might improve the efficacy of Th17-targeted therapies.
Intestinal microbiota are associated with several autoimmune diseases, including rheumatoid arthritis (RA). Mucosal surfaces such as periodontal, lung, and intestinal tissues are a proposed site of immune activation and breach of tolerance in RA (1) . However, the extent and nature of the mucosal immune activation during preclinical arthritis are unclear. Several independent studies have demonstrated perturbed diversity and composition of commensal microbiota in patients with RA compared with healthy individuals (2) (3) (4) (5) . However, the relationship between dysbiosis and the pathogenesis of RA is not fully understood.
The microbiome profoundly affects the balance between inflammatory CD4+ Th1 cells and Th17 cells and protective Treg cells, both at mucosal surfaces and systemically (6) . Specific taxa, such as segmented filamentous bacteria (SFB), enhance differentiation of Th17 cells in the small intestine (SI) lamina propria (7, 8) . SFB Supported by the Arthritis National Research Foundation (grant 15-A0-00-004310) and Reumafonds (grants 16-1-403 and AFS 14-1-291). 1 Heather Evans-Marin, PhD, Sergei B. Koralov, PhD, Julia Manasson, MD, Jose U. Scher, MD: New York University School of Medicine, New York, New York; 2 Rebecca Rogier, MSc, Debbie Roeleveld, MSc, Peter M. van der Kraan, PhD, Marije I. Koenders, PhD: Radboud University Medical Center, Nijmegen, The Netherlands; colonization exacerbates spontaneous arthritis in interleukin-1 (IL-1) receptor antagonist-deficient and K/BxN mice (9, 10) . In addition, in SKG mice with increased thymic selection of autoreactive T cells (11) , colonization of Prevotella copri, a commensal species associated with newonset RA (2, 3) , led to increased abundance of SI lamina propria Th17 cells and enhanced arthritis upon concomitant exposure to zymosan (3) . Although these studies showed that Th17 cell-inducing intestinal microbiota exacerbate arthritis, it is not known whether involvement of these microbiota-induced Th17 cells is required for the pathogenesis of arthritis.
Inhibition of either IL-17A or its receptor ameliorates arthritis in mice (12) (13) (14) (15) . Although blockade of IL-17 resulted in clinically relevant improvement based on the American College of Rheumatology 50% improvement response criteria in~20% of patients with RA, convincing efficacy in the overall population was not observed (16) (17) (18) . Importantly, Th17 cells produce other proinflammatory mediators, such as IL-17F, IL-22, tumor necrosis factor a (TNFa), and granulocyte-macrophage colonystimulating factor (GM-CSF), which have IL-17A-independent proinflammatory roles (13, (19) (20) (21) . Therefore, the role of Th17 cells in RA likely extends beyond the production of IL-17A. Previous studies in animal models have assessed the role of Th17 cells in IL-17-deficient mice, and clinical trials have evaluated the effects of IL-17-blocking antibodies. Because several cell types other than Th17 cells produce IL-17 (13, 22) , the specific contribution of Th17 cells to the pathogenesis of arthritis is unclear.
Enrichment of Th17 cells in vivo strongly depends on the presence and composition of intestinal microbiota (7, 8, 23) . Accordingly, the intestinal mucosa is a major anatomic compartment of Th17 cells (7, 8) , and the involvement of Th17 cells in arthritis may be highly dependent on the composition of the host microbiota. Our aim was to determine the role of Th17 cells in arthritis pathogenesis and investigate whether the involvement of Th17 cells in arthritis depends on the microbiota present in the gut prior to disease development. In addition, we hypothesized that mucosal immune activation occurs in the preclinical phase and precedes the onset of arthritis.
MATERIALS AND METHODS
Mice. Th17 cell-deficient mice (CD4-Cre + Rorc flox/flox ) on a C57BL/6 background were generated by crossing B6 (Cg)-Rorc tm3Litt/J with B6.Cg-Tg(Cd4-cre) mice (stock nos. 008771 and 022071; The Jackson Laboratory) (24, 25) . CD4-Cre À Rorc flox/flox mouse littermates were used as wild-type (WT) control mice. Experimental groups consisted of randomized age-and sex-matched Cre + and Cre À co-housed littermates. Mice were housed in individually ventilated cages and were provided autoclaved food and water ad libitum. All animal studies were approved by our Institutional Review Board, and were conducted in accordance with institutional guidelines.
Antibiotic treatments and reconstitution with Jackson microbiota. Age-and sex-matched groups of CD4-Cre + Rorc flox/flox and CD4-CreÀRorc flox/flox mice received an antibiotic cocktail of metronidazole, neomycin trisulfate, ampicillin sodium salt, vancomycin, and sucrose that was added to drinking water for 1 week. Microbiota were then reconstituted by oral gavage of a 200-ll aqueous suspension of SFB-free feces from Jackson mice, at 24 hours after cessation of the antibiotics. The SFB-free status of the mice was confirmed by quantitative polymerase chain reaction (qPCR), as reported previously (10, 26) .
Isolation of lamina propria cells. Mesenteric fat and Peyer's patches were removed from the small intestine and colon. Tissue was incubated with 5 mM EDTA to remove epithelial cells, and subsequently was digested with 1 mg/ml collagenase D and 10 lg/ml DNAse I. Lamina propria lymphocytes were harvested at the interphase of a 40%:80% Percoll gradient and utilized in the experiments described below.
Cell cultures and cytokine measurements. SI lamina propria or mesenteric lymph node (LN) cells (1-2 9 10 5 cells/ well) were cultured in 96-well round-bottomed plates. Supernatants were collected after 6 hours from cells stimulated with phorbol myristate acetate (PMA) (50 ng/ml) and ionomycin (1 lg/ml), or after 2 days from cells stimulated with collagen (50 lg/ml). Cytokine levels were measured by Luminex assay using Bio-Rad magnetic bead kits specific for mouse cytokine groups 1 and 3, in accordance with the manufacturer's instructions.
Flow cytometry. Prior to flow cytometry staining, cells were restimulated with PMA (50 ng/ml; Sigma), ionomycin, and brefeldin A for 4 hours. Staining protocols and reagents are described in Supplementary Methods and listed in Supplementary Table 1 (available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40657/abstract). Cells were fixed in 2% paraformaldehyde and stored at 4°C until acquisition with an LSRII flow cytometer. Analysis of the findings was performed in FlowJo.
Fluorescence-activated cell sorting. Splenocytes were stained with surface markers, and then resuspended in T cell medium and sorted with a FACSAria II using the following parameters: T cell receptor b-positive (TCRb+), viability dyenegative cells were positively selected, followed by additional positive selection using gating on CD4 and CD8 single-positive cells.
Induction of antigen-induced arthritis (AIA). To induce AIA, mice were treated with 200 lg methylated bovine serum albumin (mBSA) in saline, administered intraarticularly into the footpad, and with 250 ng IL-1b in saline, administered subcutaneously into the footpad, with additional IL-1b treatments at 24 and 48 hours thereafter (27, 28) . Mice were euthanized on day 7, during the peak of the inflammatory response (27, 28) .
Induction of collagen-induced arthritis (CIA). CIA was induced via 2 intradermal immunizations with 100 ll of an emulsion consisting of a 1:1 ratio of chicken type II collagen (CII) (4 mg/ml in 10 mM acetic acid) and Freund's complete adjuvant, based on previously published protocols optimized for the BL/6 background (29,30). Freund's complete adjuvant was prepared by adding 5 mg desiccated Mycobacterium tuberculosis H37RA (Difco) per 1 ml Freund's incomplete adjuvant. Primary immunization was administered in the tail base of mice at ages 10-12 weeks. The mice received a booster in the lower back on day 21, and were monitored for clinical signs of arthritis. All mice developed mild arthritis.
Assessment of arthritis. The severity of arthritis was scored in a blinded manner, as described previously (31) . For histology, ankle joints were isolated and fixed in 4% formaldehyde for 4 days, and thereafter decalcified in 5% formic acid and embedded in paraffin. Tissue sections (7 lm) were stained using hematoxylin and eosin or Safranin O. Synovial inflammation, chondrocyte death, proteoglycan depletion, and erosion of hyaline cartilage were scored in a blinded manner on a scale of 0-3 (31) .
DNA qPCR and 16S sequencing. Mouse genomic DNA was extracted from sorted CD4+ and CD8+ splenocytes with a QIAamp DNA Mini kit (Qiagen), in accordance with the manufacturer's instructions. Fecal pellets were collected and stored at À20°C. Extraction of DNA was performed with a PowerLyzer DNA isolation kit (MO BIO Laboratories), in accordance with the manufacturer's instructions. Quantitative PCR was performed on the StepOne System (Applied Biosystems) using a SYBR FAST Master Mix (KAPA Biosystems). The sequencing methods used are extensively described in Supplementary Methods, and a complete list of the primers used is shown in Supplementary 
RESULTS
Characterization of mucosal immune activation preceding the onset of arthritis. Modulation of the intestinal immune response by commensal microbiota affects the inflammation patterns and immunopathologic features at distal anatomic sites, including the joints (9, 10, 32, 33) . To investigate mucosal immune activation during preclinical arthritis, we assessed intestinal CD4+ T cell cytokine responses before arthritis onset in WT mice 21 days after a single immunization with CII. We found that immunization of the mice with CII induced a robust T cell response in the SI lamina propria, with significantly increased percentages of both Th1 and Th17 cells (Figures We observed no difference in CD4+ T cell cytokine production in the colonic lamina propria of naive mice compared with immunized mice (data not shown), suggesting that mucosal immune activation in response to CII immunization is restricted to the SI lamina propria.
Because Th17 cells produce multiple cytokines (20, 22) , we examined whether CII immunization specifically altered the production of these cytokines by Th17 cells. SI lamina propria and mesenteric LN Th17 cells from immunized mice exhibited significantly higher coexpression of IL-22 compared with naive mice ( Figure 1D ). In addition, Th17 cell coexpression of IL-22 and GM-CSF was increased in the Peyer's patches of immunized mice compared with naive mice ( Supplementary Figure 1D [http://onlinelibrary.wiley.com/doi/10.1002/art.40657/ abstract]). These data suggest that activation of intestinal CD4+ T cells and increased production of mucosal Th1 and Th17 cells precede the development of arthritis in mice.
Specific reduction of Th17 cells but unaffected IL-17 production by other cellular sources in Th17 celldeficient mice. Results from previous studies using IL-17 neutralizing antibodies or IL-17-deficient mice suggested that IL-17 has a role in the pathogenesis of arthritis (14, 15, (34) (35) (36) (37) . However, because IL-17 is produced by multiple cell types other than Th17 cells, such as neutrophils and mast cells (13, 38, 39) , the role of, and requirement for, Th17 cells specifically has not been established. Notably, IL-17 deficiency protects against innate cell-mediated K/BxN serum-transfer arthritis (14, 15, 40, 41) . To directly examine the role of Th17 cells in the development of arthritis, we utilized conditional Th17-deficient mice. Th17 ablation in these mice is achieved through a CD4-specific Cre recombinase-induced deletion of a floxed Rorc allele, which prevents the expression of retinoic acid receptor-related orphan nuclear receptor ct (RORct) and thus inhibits differentiation of naive CD4 Tcells into Th17 cells (42) . CD4-Cre +/À STAT3 flox/flox mice, which is another type of Th17-deficient mouse strain, were not utilized in our studies because production of the Th1 and T follicular helper cell subsets is impaired in these mice (43, 44) .
To confirm that CD4-Cre Since cytokine production was relatively low in naive mice, we sought to confirm specific Th17 cell deficiency in antigen-experienced Cre + mice. We euthanized naive and CII-immunized CD4-Cre (Figure 2D) . As was observed in naive mice, the abundance of Th17 cells was significantly reduced in immunized Cre + mice compared with immunized Cre À mice (Figure 2D) . In contrast, the numbers of intestinal Th1 cells were similarly increased in both Cre + and Cre À mice upon immunization ( Figure 2D ). These data We further investigated the expression of IL-17A by CD4À immune cells during the development of AIA. We found no significant difference in the frequency or mean fluorescence intensity (MFI) of IL-17A within SI lamina propria CD11b+Gr-1+ neutrophils between Cre + and Cre In SFB-specific qPCR analyses, we demonstrated that the mice harbored SFB (data not shown), a taxa known to induce the differentiation of Th17 cells and to exacerbate arthritis in K/BxN mice (9) . Nevertheless, studies have yet to demonstrate whether the involvement of these induced Th17 cells is required for arthritis, and the role of IL-17 in SFB-induced exacerbation of K/BxN arthritis has also been a subject of recent debate (45, 46) . Evaluation of CIA in our SFB-positive mice revealed that conditional Th17 cell-deficient (Cre + ) mice had significantly lower arthritis severity scores compared with Cre À littermate mice beginning 36 days after the primary immunization ( Figure 5A ). The severity of knee arthritis was also significantly lower in Cre + mice compared with Cre À mice at the study end point ( Figure 5A ). Histopathologic examination of the ankle joints confirmed significantly less synovial inflammation, proteoglycan depletion, chondrocyte death, and cartilage erosion in Cre + mice compared with Cre À mice ( Figures 5B  and C) . These data indicate that Th17 cells are required for the development and progression of chronic inflammatory arthritis in the CIA model.
To assess the effects of Th17 cell deficiency on the gut microbiota, we performed high-throughput 16S ribosomal RNA gene sequencing of fecal microbiota from CD4-Cre flox/flox mice (47) . In contrast, the levels of SFB were significantly decreased in flox/flox mice with arthritis. Evidence that Th17 cell contributions to arthritis are microbiota-dependent. Because the composition of the intestinal microbiota strongly influences the induction of systemic and mucosal Th17 cells, we evaluated whether the requirement of Th17 cells for arthritis development was dependent on the microbiota present in the gut. We depleted the native (SFB+) microbiota of CD4-Cre + Rorc flox/flox and CD4-Cre À Rorc flox/flox mice with broadspectrum antibiotics, and reconstituted the mice with SFB-free fecal microbiota obtained from Jackson mice (7) . After recolonization of the mice with SFB-free and Cre À mice were depleted of native microflora and reconstituted with SFB-free microbiota from Jackson mice before the induction of CIA.
Arthritis severity was scored in the same manner as described in A. Results are the mean AE SEM from a representative experiment in 4-5 mice per group. * = P < 0.05; ** = P < 0.01, by Mann-Whitney U test (for 2 groups) or two-way repeated-measures analysis of variance with uncorrected Fisher's least significant difference test (for groups over multiple time points). D = day; ND = not determined.
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Jackson microbiota, CIA was induced and scores of arthritis severity were assessed. We observed no significant differences in arthritis severity for the duration of the experiment between Cre + and Cre À mice that had been reconstituted with Jackson microbiota (Figure 5D ).
The composition of the fecal microbiota observed in these mice was determined by 16S sequencing (Supplementary Figure 8 Table 4 [http://onlinelibrary.wiley. com/doi/10.1002/art.40657/abstract]). The significance of the difference was eliminated after correction for multiple testing. SFB were not detected by qPCR in the feces from Jackson microbiota-reconstituted mice at the end point of the experiment. These data suggest that the Th17 cell dependency of inflammatory arthritis relies on the microbiota-specific activation of mucosal Th17 cell immunity.
Disparate roles of Th17 cells and IL-17A in arthritis pathogenesis. Having established a contextual, microbiota-dependent role of Th17 cells during arthritis pathogenesis, we examined cytokine expression in the SI lamina propria and draining LNs of CD4-Cre + Rorc flox/flox and CD4-Cre À Rorc flox/flox mice with CIA. Consistent with our previous observations (see Figure 2) , the frequency and MFI of IL-17A expression were decreased in SI lamina propria CD4+ T cells from Cre + mice compared with Cre À mice during CIA ( Figure 6A ). However, quantification of IL-17A from the supernatants of SI lamina propria cells stimulated with PMA and ionomycin revealed that total SI lamina propria IL-17A production was not significantly affected in Th17 cell-deficient mice, and tended to be higher than that in Th17 cellÀsufficient mice (P = 0.63) ( Figure 6B ). These findings suggest that non-Th17 cells, such as neutrophils and cd T cells (see Figure 4) showed no significant difference in IL-17A production after stimulation with PMA and ionomycin ( Figure 6C) . Interestingly, the PMA and ionomycin-stimulated draining LNs of Cre + mice had significantly higher concentrations of IFNc compared with draining LNs from Cre À mice ( Figure 6C ). We observed no difference between the 2 genotypes in draining LN cell production of GM-CSF (mean AE SEM 10.56 AE 1.68 pg/ml in Cre À mice versus 12.59 AE 2.72 in Cre + mice) or IL-17F (15.68 AE 3.76 pg/ml in Cre À mice versus 13.14 AE 3.96 pg/ml in Cre + mice). IL-22 was not detectable in the draining LNs. However, upon stimulation with CII to determine antigen-specific cytokine responses, the levels of IL-17A, IL-17F, and GM-CSF were all significantly lower in the draining LNs of Cre + mice compared with Cre À mice ( Figure 6D ). Production of TNFa by CII-stimulated draining LNs was similar between the 2 groups, and IFNc and IL-22 were not detectable following stimulation with CII (data not shown).
These data indicate that during CIA, there is no difference in the total production of IL-17A, IL-17F, and GM-CSF by PMA and ionomycin-stimulated draining LN cells between Cre À mice and Cre + mice. However, antigen-specific cytokine production is significantly reduced in Cre + mice when compared with Cre À mice, a finding that suggests the potential involvement of Th17 cells. Thus, we may infer that the production of multiple cytokines, including IL-17A, IL-17F, and GM-CSF, by Th17 cells drives arthritic joint inflammation in this murine model.
DISCUSSION
The intestinal microbiome has emerged as a key determinant of health and disease. Culture-independent high-throughput sequencing techniques have revealed that the diversity and significant overrepresentation of Prevotella copri are reduced in patients with new-onset, untreated RA (2,3). Another study found an association of treatment-naive RA with a cluster of metagenomic linkage groups related to Clostridium asparagiforme, Gordonibacter pamelaeae, Eggerthella lenta, and Lachnospiraceae (4). Furthermore, an increased abundance of Collinsella, Eggerthella, and Faecalibacterium was identified in patients with longstanding, treated RA (mean disease duration 81.6 months) (5). However, the pathophysiologic relevance of these alterations in the microbiota in new-onset or established RA is not fully understood.
A recent study demonstrated increased lamina propria Th17 cell differentiation in SKG mice humanized with fecal microbiota from patients with new-onset RA as compared with mice harboring fecal microbiota from healthy controls (3). This coincided with more severe arthritis in the SKG mice when the mice were co-exposed to the fungal component zymosan (3). However, a requirement for the involvement of microbiota-induced Th17 cells was not demonstrated. While several studies have demonstrated that experimental arthritis can be exacerbated by SFB (9, 32, 45, 46) , it is unclear whether these arthritogenic effects are due to Th17 cell induction or due to T follicular helper cell induction and autoantibody production (45) . Microbiome perturbations occur during CIA, and the composition of the microbiota differs between both naive and arthritic CIA-susceptible and -resistant mouse strains (48) (49) (50) . Tuftsin phosphorylcholine, a natural glycoprotein with tolerogenic potential, attenuates the development of CIA and prevents dysbiosis in mice (48, 51) . Studies on microbiota-dependent differentiation of Th17 cells in the K/BxN mouse model of arthritis have demonstrated that Th17 cell induction in SFB-colonized mice occurs around weaning and precedes the onset of arthritis (9, 46) . Because age-dependent increases in SI lamina propria Th17 cells are also observed in naive mice, a side-by-side comparison between age-matched prearthritic mice and naive control mice, as was performed in the present study, is crucial to demonstrate that the increase in Th17 cells is characteristic of preclinical arthritis in mice.
Our findings demonstrate initiation of mucosal Th1 and Th17 cell responses and marked production of TNFa, GM-CSF, and IL-22 by mucosal CD4 T cells just before the clinical onset of arthritis. Furthermore, increased production of GM-CSF and IL-22 by SI lamina propria Th17 cells during preclinical arthritis is an additional novel finding. These cytokines are implicated in the pathogenesis of RA and may have IL-17-independent proinflammatory and osteoclastogenic functions (13, (20) (21) (22) . Therefore, our observations suggest that activation of intestinal mucosal T cells during the immune-priming phase of RA may contribute to early, preclinical processes.
Further studies using Th17 cell-deficient mice showed that Th17 cells are required for the progression of arthritis and affect several features of structural joint pathology in 2 murine arthritis models, mBSA-induced arthritis (AIA) and CIA. AIA is an acute nonimmunogenic and nonautoimmune model of arthritis, whereas CIA is chronic, immunogenic, and autoimmune. Chronic acute autoimmunity models frequently demonstrate differential immunogenicity, cellular involvement, and mechanisms of pathogenesis. Therefore, these 2 models provide complementary insights into the role of Th17 cells in arthritis. The known role of other cellular sources of IL-17 in arthritis (52) emphasizes the value of investigating the specific, differential contribution of Th17 cells as a main source of IL-17 and other proinflammatory mediators.
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In our comparison of the effects of CD4-induced Rorc deletion between the acute AIA and CIA models, we found that the AIA model is less dependent on Th17 cells. This aligns with previous observations of the role of the cytokine IL-17A in these 2 models (28, 35, 53, 54) . This may be attributable to the B cell and antibody dependence of CIA as compared to acute AIA, because Th17 cells also assist B cells and promote antibody production. Conversely, AIA could reflect a predominant role of other IL-17-producing cells, such as cd T cells. Examining cd T cell-specific Rorc deletion during CIA and AIA is an avenue for future study.
Since total IL-17 production upon stimulation of T cells with PMA and ionomycin was not affected in arthritis-resistant Th17-deficient mice, it is likely that the role of Th17 cells in arthritis expands beyond that of the cytokine IL-17. Moreover, the cytokine profile of collagen-stimulated cells from the joint-draining LNs indicated that antigen-experienced T cells produced IL-17A, IL-17F, and GM-CSF, whereas the levels of these were significantly reduced in Th17 cell-deficient mice. GM-CSF activates the monocyte/macrophage system as well as neutrophils, and promotes inflammation (20) . Inhibition of GM-CSF or its receptor led to a reduction in the RA disease activity score and in the C-reactive protein levels in arthritis patients in clinical trials (20, 55, 56) . GM-CSF and IL-17A act synergistically to induce matrix metalloproteinases, RANKL, and IL-23 in the synovium, and simultaneous expression of both IL-17A and GM-CSF leads to complete destruction of the joint structure in mice (57) . Accordingly, simultaneous blockade of IL-17A and GM-CSF is more effective than blocking either cytokine alone (57) . Therefore, we attribute the reduced arthritis severity in Cre + mice to the simultaneous reduction of IL-17A, IL-17F, and GM-CSF production by antigen-specific Th17 cells.
Th17 cell production of multiple proinflammatory cytokines with synergistic effects during arthritis suggests that modulation of Th17 cell development may be more effective than IL-17 blockade. This may extend to other rheumatic inflammatory diseases, such as psoriatic arthritis, in which Th17 cells play a pathogenic role (58) . In addition, direct effects of Th17 cells on B cell activation and isotype class switching as well as facilitation of antibody production have been reported, and may represent other important IL-17-independent roles for Th17 cells (59, 60) .
While T cell IL-22 expression was increased in immunized mice during preclinical arthritis (Figures 1B-D) , IL-22 was not detectable in culture supernatants derived from the SI lamina propria or draining LNs of mice with fulminant CIA. Therefore, the role of IL-22-producing mucosal T cells in arthritis remains unclear, and may be restricted to the preclinical phase.
Differentiation of the Th17 cell lineage is mediated by both RORa and RORct transcription factors (61) . Intact RORa expression in CD4-expressing cells may explain why the Th17 cell deficiency in CD4-Cre + Rorc flox/flox mice is incomplete. Studies of Rora/Rorct double-deficient mice with fully impaired Th17 cell development (61) would help clarify whether arthritis is fully inhibited in the complete absence of Th17 cells.
Th17 cells and IL-17 production are strongly induced by intestinal microbiota (8, 9, 23) . Therefore, the microbiota composition strongly influences the dominant immune processes underlying disease in certain patients. Th17 cell frequencies are elevated in RA, particularly in patients with poor responses to TNFa inhibitors (13, 62) . Our data show that in the absence of specific murine Th17 cell-inducing microbiota, namely SFB, the Th17 cell dependence of arthritis is mitigated. Therefore, Th17 cells contribute to the pathogenesis of arthritis only in the context of specific microbiota. This suggests that the composition of the microbiota in each patient may be a major factor affecting the involvement of the Th17/IL-17 pathway in mucosal immunity and RA. Thus, the microbiome profile of a patient may be a valuable biomarker for predicting the efficacy of Th17 cell-or IL-17-targeted therapies. We therefore speculate that microbiome-guided stratification of patients with inflammatory arthritis may improve therapeutic efficacy.
